Prenetics Global Limited (NASDAQ: PRE)
$4.5800
+0.1600 ( -1.08% ) 0.3K
Prenetics Global Ltd is a health sciences company, that is dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.
Market Data
Open
$4.5800
Previous close
$4.4200
Volume
0.3K
Market cap
$54.00M
Day range
$4.4950 - $4.6900
52 week range
$2.8500 - $7.8380
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
6-k | Form 6-K | 3 | May 20, 2024 |
20-f | Annual reports | 199 | May 01, 2024 |
6-k | Form 6-K | 5 | Apr 01, 2024 |
20-f | Annual reports | 152 | Mar 25, 2024 |
6-k | Form 6-K | 3 | Mar 25, 2024 |
6-k | Form 6-K | 3 | Feb 15, 2024 |
6-k | Form 6-K | 3 | Jan 09, 2024 |
6-k | Form 6-K | 1 | Nov 30, 2023 |
6-k | Form 6-K | 2 | Nov 20, 2023 |
6-k | Form 6-K | 2 | Nov 13, 2023 |